project id: TCGA-PRAD; case submitter id: TCGA-EJ-8469; selected normal wgs: true; state: released; age at index: 46; days to birth: -17014; ethnicity: not reported; gender: male; race: black or african american; vital status: Alive; year of birth: 1961; age at diagnosis: 17014; ajcc clinical m: M0; ajcc clinical t: T3a; ajcc pathologic n: N0; ajcc pathologic t: T3a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2324.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 40.0; intermediate dimension: 1.0; longest dimension: 2.3; preservation method: Unknown; shortest dimension: 0.5; sample id: 0c6f048a-0b88-48ed-9e96-fc076d6ffa67; sample submitter id: TCGA-EJ-8469-01A; portion id: eed15151-4a68-49ae-99a4-c5aff12e6d77; portion submitter id: TCGA-EJ-8469-01A-11; percent necrosis: 0.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;